RENALYTIX AI PLC - AMERICAN DEPOSITARY SHARES
RENALYTIX AI PLC - AMERICAN DEPOSITARY SHARES
Certificado de depósito · US75973T1016 · RNLX · A2P9A5 (XNAS)
Resumen
Sin cotización
n/a

Rendimiento

Día Semana Mes 3 meses 6 meses 1 año 5 años
- - - - 0,00 % -54,60 % -98,47 %

Perfil de la empresa para RENALYTIX AI PLC - AMERICAN DEPOSITARY SHARES Certificado de depósito

Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data from electronic health record systems to generate a unique patient risk score. Its products are used in kidney disease diagnosis and prognosis, clinical care, patient stratification for drug clinical trials, and drug target discovery. Renalytix AI plc has a license agreement with Mount Sinai Health System to develop and commercialize licensed products in connection with the application of artificial intelligence for the diagnosis of kidney disease; Joslin Diabetes Center, Inc. for developing and commercializing products for diagnosing and predicting kidney disease using biomarkers; and Kantaro Biosciences LLC for developing and commercializing laboratory tests for the detection of antibodies against SARS-CoV-2. The company also has a partnership agreement with Atrium Health, Wake Forest Baptist Health, and Wake Forest School of Medicine to implement an advanced clinical care model designed to improve kidney health and reduce kidney disease progression and kidney failure in high-risk populations. The company was formerly known as Renalytix AI plc and changed its name to Renalytix Plc in June 2021. Renalytix Plc was incorporated in 2018 and is headquartered in New York, New York.

Datos de la empresa

Nombre RENALYTIX AI PLC - AMERICAN DEPOSITARY SHARES
Empresa Renalytix Plc
Símbolo RNLX
Sitio web https://renalytix.com
Mercado principal XNAS NASDAQ
WKN A2P9A5
ISIN US75973T1016
Tipo de valor Certificado de depósito
Sector Healthcare
Industria Medical - Healthcare Information Services
CEO Mr. James R. McCullough M.B.A.
Capitalización de mercado 23 Mio
País Estados Unidos de América
Moneda USD
Empleados 0,1 T
Dirección 1460 Broadway, 10036 New York
Fecha de OPV 2020-07-17

Símbolos de cotización

Nombre Símbolo
Frankfurt 2O9A.F
NASDAQ RNLX

Otras acciones

Los inversores que tienen RENALYTIX AI PLC - AMERICAN DEPOSITARY SHARES también tienen las siguientes acciones en su cartera:
DIXIE GOLD INC
DIXIE GOLD INC Acción
TEKKORP DIGITAL ACQUISITION CORP - CLASS A
TEKKORP DIGITAL ACQUISITION CORP - CLASS A Acción
La plataforma financiera MoneyPeak rastrea y analiza inversiones y carteras. Desde depósitos de valores hasta compras de criptomonedas.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.
Aviso legal Protección de datos Blog Comunidad Comentarios Changelog
Im App Store herunterladen Bei Google Play herunterladen
Todos los derechos reservados © LCP GmbH 2025